SSY GROUP (02005.HK): trustee buys 400,000 shares under restricted share award scheme at average HK$2.6122
NewTimeSpace News: SSY GROUP (02005.HK) announced that on 28 October 2026, funded by the Company's internal resources, the trustee of the restricted share award scheme adopted by the Company on 27 December 2018 purchased an aggregate of 400,000 shares of the Company on the open market in accordance with the terms and conditions of the scheme, and holds such shares in trust for the selected participants.
According to the announcement, the shares purchased represent approximately 0.014% of the total number of issued shares of the Company as at the date of the announcement, the average consideration per share (excluding expenses) was approximately HK$2.6122 and the total consideration paid for the purchased shares (excluding expenses) was approximately HK$1,044,900. Immediately after the purchase, the balance of shares held by the trustee was 16,780,000 shares, representing approximately 0.569% of the total number of issued shares of the Company.
The Board said it will review from time to time and determine at its absolute discretion the number of shares it considers appropriate to grant to the selected participants. The announcement did not disclose the specific arrangements or timetable for granting award shares following this purchase.
- CSPC PHARMA (01093.HK): Phase II Trial in China of SYH2066 for RSV Launched
- SSY Group (02005.HK): labetalol API registration approved by China's NMPA
- SSY GROUP (02005.HK): Nimodipine oral solution wins production nod
- SSY GROUP (02005.HK): Ziprasidone Mesylate Approved for Registration as API for Use in Marketed Formulations
- SSY GROUP (02005.HK): Wins NMPA approval for Letermovir Injection, deemed to have passed consistency evaluation